Canada - English - Health Canada

hikma canada limited - cefazolin (cefazolin sodium) - powder for solution - 10g - cefazolin (cefazolin sodium) 10g - first generation cephalosporins

Canada - English - Health Canada

baxter corporation - cefazolin (cefazolin sodium) - solution - 20mg - cefazolin (cefazolin sodium) 20mg

Canada - English - Health Canada

sterimax inc - cefazolin (cefazolin sodium) - powder for solution - 2g - cefazolin (cefazolin sodium) 2g

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefazolin sodium 1.048 g equivalent to 1 g cephazolin (2% fill overage) - powder for injection - 1 g - active: cefazolin sodium 1.048 g equivalent to 1 g cephazolin (2% fill overage) excipient: nitrogen

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefazolin sodium 524mg equivalent to 500 mg cephazolin (5% fill overage) - powder for injection - 500 mg - active: cefazolin sodium 524mg equivalent to 500 mg cephazolin (5% fill overage) excipient: nitrogen

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

hankook korus pharm co. - cefazolin (cefazolin sodium) - powder for solution for i/m and i/v injection - 1000mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefazolin sodium 524mg equivalent to cefazolin 500 mg - powder for injection - 0.5 g - active: cefazolin sodium 524mg equivalent to cefazolin 500 mg - due to s. pneumoniae, klebsiella sp, h. influenzae, staph. aureus (including penicillinaseproducing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefazolin sodium 1048mg equivalent to cefazolin 1000 mg - powder for injection - 1 g - active: cefazolin sodium 1048mg equivalent to cefazolin 1000 mg - due to s. pneumoniae, klebsiella sp, h. influenzae, staph. aureus (including penicillinaseproducing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefazolin sodium 2096mg equivalent to cefazolin 2000 mg - powder for injection - 2 g - active: cefazolin sodium 2096mg equivalent to cefazolin 2000 mg - due to s. pneumoniae, klebsiella sp, h. influenzae, staph. aureus (including penicillinaseproducing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - cefazolin sodium, quantity: 2096 mg - injection, powder for - excipient ingredients: - cefazolin is indicated in the treatment of the following serious infections due to susceptible organisms:,respiratory tract infections due to s. pneumoniae, klebsiella species, h. influenzae, staph. aureus (penicillin-sensitive and penicillin- resistant), and group a beta-haemolytic streptococci.,injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever.,cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.,genitourinary tract infections due to esch. coli, pr. mirabilis, klebsiella species, and some strains of enterobacter and enterococci.,skin and skin structure infections due to staph. aureus (penicillin-sensitive and penicillin- resistant), and group a beta-haemolytic streptococci and other strains of streptococci.,bone and joint infections due to staph. aureus.,septicaemia due to s. pneumoniae, staph. aureus (penicillin-sensitive and penicillin-resistant), pr. mirabilis, esch. coli and klebsiella species.,endocarditis due to staph. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-haemolytic streptococci.,appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefazolin.